Fiera Capital (Europe)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$290K Hold
8,923
0.14% 26
2016
Q4
$274K Sell
8,923
-3,960
-31% -$121K 0.16% 26
2016
Q3
$414K Sell
12,883
-6,855
-35% -$229K 0.24% 22
2016
Q2
$657K Sell
19,738
-1,315
-6% -$42K 0.51% 16
2016
Q1
$593K Hold
21,053
0.58% 17
2015
Q4
$647K Hold
21,053
0.77% 17
2015
Q3
$627K Buy
21,053
+1,519
+8% +$48.7K 0.83% 17
2015
Q2
$622K Hold
19,534
0.57% 19
2015
Q1
$647K Buy
19,534
+18,303
+1,487% +$582K 0.59% 19
2014
Q4
$143 Sell
1,231
-18,303
-94% -$525K 0.11% 39
2014
Q3
$550K Hold
19,534
0.4% 23
2014
Q2
$550K Sell
19,534
-21
-0.1% -$599 0.44% 21
2014
Q1
$596K Buy
19,555
+1,712
+10% +$51K 0.45% 18
2013
Q4
$519K Buy
+17,843
New +$519K 0.29% 20

Other funds holding PFE

Fiera Capital (Europe)'s PFE Position: Q1 2017 in Review

Fiera Capital (Europe) held its Pfizer (PFE) position steady in Q1 2017 at 8,923 shares worth $290K. The position accounts for 0.14% of the portfolio, ranked #26.

Fiera Capital (Europe) first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $657K in Q2 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Fiera Capital (Europe) held 8,923 shares of Pfizer worth $290K as of Q1 2017.
  • Fiera Capital (Europe) left its Pfizer share count unchanged in Q1 2017.
  • Pfizer made up 0.14% of Fiera Capital (Europe)'s portfolio in Q1 2017, its #26 holding.
  • Fiera Capital (Europe) first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
  • Fiera Capital (Europe)'s Pfizer position peaked at $657K in Q2 2016.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2017, filed 15 May 2017.